Liver Diseases  >>  Doptelet (avatrombopag)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doptelet (avatrombopag) / SOBI
NCT01972529 / 2013-000965-34: Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Completed
3
231
US, Canada, Europe, RoW
avatrombopag (lower baseline platelet count), placebo (lower baseline platelet count), avatrombopag (higher baseline platelet count), placebo (higher baseline platelet count)
Eisai Inc.
Thrombocytopenia Associated With Liver Disease
01/17
02/17
NCT01976104 / 2013-000934-36: Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Completed
3
204
Japan, US, Canada, Europe, RoW
avatrombopag (lower baseline platelet count), placebo (lower baseline platelet count), avatrombopag (higher baseline platelet count), placebo (higher baseline platelet count)
Eisai Inc.
Thrombocytopenia Associated With Liver Disease
01/17
02/17

Download Options